Yahoo
NSE - Delayed Quote INR

Metropolis Healthcare Limited (METROPOLIS.NS)

545.65 -8.20 (-1.48%)
At close: October 30 at 3:29:52 PM GMT+5:30
Chart Range Bar
Loading chart for METROPOLIS.NS
  • Previous Close 553.85
  • Open 551.20
  • Bid --
  • Ask --
  • Day's Range 541.15 - 556.70
  • 52 Week Range 412.25 - 609.05
  • Volume 49,770
  • Avg. Volume 235,717
  • Market Cap (intraday) 113.202B
  • Beta (5Y Monthly) 0.20
  • PE Ratio (TTM) 56.19
  • EPS (TTM) 9.71
  • Earnings Date Nov 3, 2026
  • Forward Dividend & Yield 2.00 (0.37%)
  • Ex-Dividend Date May 19, 2026
  • 1y Target Est 666.05

Metropolis Healthcare Limited, together with its subsidiaries, provides pathology and related healthcare services in India and internationally. The company offers routine and specialised pathology tests; advanced diagnostics, including genetic, molecular, and cytogenetic testing; preventive healthcare packages and corporate wellness screening; clinical trial research, hospital lab management, and home collection services; radiology services, including X-ray, sonography and ECG; and next-generation sequencing services. It also provides diagnostic services for oncology, chronic and infectious diseases, gastroenterology, neurology, nephrology, and women and child health, as well as various health checkup and laboratory services. The company serves a range of customers, including direct-to-consumer diagnostics through patient service centers, mobile app, website, and home collection; partnerships with standalone labs, hospital chains, and diagnostic networks; and institutional clients, such as corporates, government bodies, and hospital lab management services. Metropolis Healthcare Limited was founded in 1980 and is headquartered in Mumbai, India.

www.metropolisindia.com

4,484

Full Time Employees

March 31

Fiscal Year Ends

Healthcare

Sector

Recent News

View More

Performance Overview

Trailing total returns as of 10/30/2026, which may include dividends or other distributions. Benchmark is S&P BSE SENSEX (^BSESN) .

YTD Return

METROPOLIS.NS
13.38%
S&P BSE SENSEX (^BSESN)
12.63%

1-Year Return

METROPOLIS.NS
11.65%
S&P BSE SENSEX (^BSESN)
11.78%

3-Year Return

METROPOLIS.NS
57.43%
S&P BSE SENSEX (^BSESN)
16.14%

5-Year Return

METROPOLIS.NS
25.09%
S&P BSE SENSEX (^BSESN)
25.55%

Earnings Trends

View More

Earnings Per Share

GAAP
Normalized
GAAP
Normalized

Revenue vs. Earnings

Annual
Quarterly
Annual
Quarterly
Q4 FY26
Revenue 4.25B
Earnings 509.03M
Profit Margin 11.99%

Q1

FY26

Q2

FY26

Q3

FY26

Q4

FY26

0
1B
2B
3B
4B
10.5%
11.0%
11.5%
12.0%

Analyst Insights

View More

Analyst Price Targets

550.00
666.05 Average
545.65 Current
760.00 High

Analyst Recommendations

  • Strong Buy
  • Buy
  • Hold
  • Underperform
  • Sell

Statistics

View More

Valuation Measures

Annual
  • Market Cap

  • Enterprise Value

  • Trailing P/E

  • Forward P/E

  • PEG Ratio (current)

  • Price/Sales (ttm)

  • Price/Book (mrq)

  • Enterprise Value/Revenue

  • Enterprise Value/EBITDA

Financial Highlights

Profitability and Income Statement

  • Profit Margin

    11.79%

  • Return on Assets (ttm)

    --

  • Return on Equity (ttm)

    --

  • Revenue (ttm)

    17.1B

  • Net Income Avi to Common (ttm)

    2.02B

  • Diluted EPS (ttm)

    9.71

Balance Sheet and Cash Flow

  • Total Cash (mrq)

    2.03B

  • Total Debt/Equity (mrq)

    15.21%

  • Levered Free Cash Flow (ttm)

    --

Company Insights

Research Reports

View More

People Also Watch

Mobilize your Website
View Site in Mobile | Classic
Share by: